Surrozen Inc Asset Turnover Ratio (SRZN), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Surrozen Inc   (NASDAQ: SRZN)
 

Surrozen Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2026, Surrozen Inc has not recorded any assets.
Visit Surrozen Inc Balance sheet

Within sector 48 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 3010 to 3355.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRZN Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 15.94 % 12.57 % 5.12 % 132.33 % 95.94 %
Y / Y Revenue Change - 408.65 % 408.65 % -19.39 % -90.17 %
Asset Turnover Ratio (TTM) - 0.11 0.07 0.03 0.04
SRZN's Total Ranking # 3355 # 3010 # 2643 # 3362 #
Seq. Asset Change -5.68 % -4.23 % 22.27 % 4.98 % -8.42 %
Seq. Revenue Change - 0 % 846.97 % -46.29 % 0 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 49
Healthcare Sector # 474
Overall Market # 3355

Asset Turnover Ratio Statistics
High Average Low
0.16 0.08 0.03
(Jun 30 2025)  




SRZN Company Profile • Back to SRZN Efficiency Comparisons • Compare SRZN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Neogen Corporation  0.26 $ 884.120  Millions$ 3,363.009  Millions
Autolus Therapeutics Plc  0.26 $ 137.434  Millions$ 533.104  Millions
Cryoport inc   0.25 $ 192.439  Millions$ 758.937  Millions
Bio rad Laboratories Inc   0.25 $ 2,593.000  Millions$ 10,350.400  Millions
Revvity Inc  0.25 $ 2,941.761  Millions$ 11,925.295  Millions
Coherus Oncology inc   0.24 $ 53.639  Millions$ 221.663  Millions
Assembly Biosciences Inc   0.23 $ 67.012  Millions$ 287.304  Millions
Sutro Biopharma Inc   0.23 $ 45.107  Millions$ 196.732  Millions
Seastar Medical Holding Corp  0.22 $ 2.165  Millions$ 9.845  Millions
Abeona Therapeutics Inc   0.22 $ 41.912  Millions$ 192.374  Millions
Beyond Air Inc   0.21 $ 7.299  Millions$ 35.326  Millions
Atara Biotherapeutics Inc   0.20 $ 4.019  Millions$ 19.966  Millions
4d Molecular Therapeutics Inc   0.19 $ 96.063  Millions$ 500.245  Millions
Teleflex Incorporated  0.19 $ 1,283.675  Millions$ 6,716.220  Millions
Elutia Inc   0.18 $ 9.637  Millions$ 52.350  Millions
Maxcyte inc   0.18 $ 34.374  Millions$ 191.034  Millions
Septerna Inc   0.16 $ 96.268  Millions$ 588.004  Millions
Lexicon Pharmaceuticals Inc   0.16 $ 38.537  Millions$ 236.472  Millions
Lucid Diagnostics Inc   0.15 $ 5.437  Millions$ 35.332  Millions
Wave Life Sciences Ltd   0.15 $ 87.296  Millions$ 572.074  Millions
Omniab Inc   0.14 $ 40.211  Millions$ 293.935  Millions
Standard Biotools Inc   0.14 $ 83.592  Millions$ 617.355  Millions
Ligand Pharmaceuticals Incorporated  0.14 $ 253.827  Millions$ 1,879.020  Millions
Bicycle Therapeutics Plc  0.13 $ 83.528  Millions$ 635.938  Millions
Kura Oncology Inc   0.12 $ 79.314  Millions$ 636.301  Millions
Voyager Therapeutics Inc   0.12 $ 25.108  Millions$ 211.603  Millions
Monte Rosa Therapeutics Inc   0.11 $ 70.325  Millions$ 643.493  Millions
Beam Therapeutics Inc   0.10 $ 146.644  Millions$ 1,404.350  Millions
Opus Genetics Inc   0.10 $ 7.914  Millions$ 76.323  Millions
Lineage Cell Therapeutics Inc   0.10 $ 10.836  Millions$ 107.112  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.